Nov 12O1.48H1.48L1.30C1.45Vol37.03k
Seres Therapeutics Inc stock is traded at $1.45, with a volume of 38,745. It is down -3.67% in the last 24 hours and down -46.08% over the past month. Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Previous Close:
$1.50
Open:
$1.48
24h Volume:
38,745
Relative Volume:
0.38
Market Cap:
$14.73M
Revenue:
$1.15M
Net Income/Loss:
-$46.90M
P/E Ratio:
-
EPS:
-$5.02
Net Cash Flow:
-$42.37M
1W Performance:
-30.86%
1M Performance:
-46.08%
6M Performance:
-81.85%
1Y Performance:
-90.97%
1-Day Range:
$1.30$1.48
1-Week Range:
$1.30$2.26
52-Week Range:
$1.30$29.98
Seres Therapeutics Inc Stock (MCRB) Company Profile
Name
Seres Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
617 945 9626Address
200 SIDNEY STREET, CAMBRIDGE, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS